Výsledky vyhledávání - Marie Ange Mouret‐Reynier

Upřesnit hledání
  1. 1
    Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

    Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer Autor Mathilde Bayet‐Robert, Fabrice Kwiatowski, Marianne Leheurteur, Françoise Gachon, E. Planchat, Catherine Abrial, Marie‐Ange Mouret‐Reynier, Xavier Durando, Chantal Barthomeuf, P. Chollet

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

    Changes and Predictive and Prognostic Value of the Mitotic Index, Ki-67, Cyclin D1, and Cyclo-oxygenase-2 in 710 Operable Breast Cancer Patients Treated with Neoadjuvant Chemothera... Autor Frédérique Penault‐Llorca, Catherine Abrial, Inès Raoelfils, P. Chollet, Anne Cayre, Marie‐Ange Mouret‐Reynier, Émilie Thivat, Florence Mishellany, Pierre Gimbergues, Xavier Durando

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

    Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse Autor Émilie Thivat, Sophie Thérondel, Olivier Lapirot, Catherine Abrial, Pierre Gimbergues, Émilie Gadéa, E. Planchat, Fabrice Kwiatkowski, Marie Ange Mouret‐Reynier, P. Chollet, Xavier Durando

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 20 years single institution study

    Mastectomy with immediate breast reconstruction after neoadjuvant chemotherapy and radiation therapy. A new option for patients with operable invasive breast cancer. Results of a 2... Autor Emilie Monrigal, J Dauplat, Pierre Gimbergues, G. Le Bouëdec, M. Peyronie, J.L. Achard, P. Chollet, Marie‐Ange Mouret‐Reynier, Jean‐Marc Nabholtz, C. Pomel

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    <i>TERT</i> promoter status and gene copy number gains: effect on <i>TERT</i> expression and association with prognosis in breast cancer

    <i>TERT</i> promoter status and gene copy number gains: effect on <i>TERT</i> expression and association with prognosis in breast cancer Autor Mathilde Gay‐Bellile, Lauren Véronèse, Patricia Combes, Eléonore Eymard‐Pierre, Fabrice Kwiatkowski, Marie-Mélanie Dauplat, Anne Cayre, Maud Privat, Catherine Abrial, Yves‐Jean Bignon, Marie‐Ange Mouret‐Reynier, Philippe Vago, Frédérique Penault‐Llorca, Andréï Tchirkov

    Vydáno 2017
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer

    Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer Autor Claire Falandry, Fréderique Rousseau, Marie‐Ange Mouret‐Reynier, Fabien Tinquaut, Domenica Lorusso, Jørn Herrstedt, Aude-Marie Savoye, Laëtitia Stefani, Emmanuelle Bourbouloux, Robert Sverdlin, Véronique D’Hondt, Alain Lortholary, Pierre-Emmanuel Brachet, Alain Zannetti, Emmanuelle Malaurie, Laurence Venat‐Bouvet, Olivier Trédan, Loı̈c Mourey, Éric Pujade-Lauraine, Gilles Freyer

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Comparison of Management and Outcomes in <i>ERBB2</i>-Low vs <i>ERBB2</i>-Zero Metastatic Breast Cancer in France

    Comparison of Management and Outcomes in <i>ERBB2</i>-Low vs <i>ERBB2</i>-Zero Metastatic Breast Cancer in France Autor Ombline de Calbiac, Amélie Lusque, Audrey Mailliez, Thomas Bachelot, Lionel Uwer, Marie‐Ange Mouret‐Reynier, George Emile, Christelle Jouannaud, Anthony Gonçalvès, Anne Patsouris, Véronique Dièras, Marianne Leheurteur, Thierry Petit, Paul Cottu, Jean-­Marc Ferrero, Véronique D’Hondt, Isabelle Desmoulins, Joana Ribeiro, Anne‐Laure Martin, Jean‐Sébastien Frénel

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes

    Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes Autor Maria Alice Franzoi, M. Aupomerol, Julie Havas, Davide Soldato, Matteo Lambertini, Claudia Massarotti, H. Hang, Barbara Pistilli, Léonor Fasse, Olivier Trédan, Emma Gillanders, Florence Joly, Paul Cottu, Marie‐Ange Mouret‐Reynier, Carole Tarpin, Antoine Arnaud, Sibille Everhard, Anne‐Laure Martin, Antonio Di Meglio, Inês Vaz-Luís

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

    Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database Autor Marcela Carausu, Matthieu Carton, Amélie Darlix, Dominique Pasquier, Marianne Leheurteur, M. Debled, Marie‐Ange Mouret‐Reynier, Anthony Gonçalvès, Florence Dalenc, Benjamin Verret, Mario Campone, Paule Augereau, Jean-­Marc Ferrero, Christelle Lévy, Jean-David Fumet, Claudia Lefeuvre‐Plesse, Thierry Petit, L. Uwer, Christelle Jouannaud, Louis Larrouquère, M. Chevrot, Coralie Courtinard, Luc Cabel

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer

    Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast canc... Autor Suzette Delaloge, Sylvain Dureau, Véronique D’Hondt, Isabelle Desmoulins, Pierre-Étienne Heudel, François P. Duhoux, Christelle Lévy, Florence Lerebours, Marie Ange Mouret‐Reynier, Florence Dalenc, Jean‐Sébastien Frénel, Christelle Jouannaud, Laurence Venat‐Bouvet, Suzanne Nguyen, C. Callens, David Gentien, Audrey Rapinat, Helene Manduzio, Anne Vincent‐Salomon, Jérôme Lemonnier, Paul Cottu

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial

    Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial Autor Hervé Bonnefoi, Florence Lerebours, Marina Pulido, Mónica Arnedos, Olivier Trédan, Florence Dalenc, Séverine Guiu, Luís Teixeira, Delphine Mollon, Christelle Levy, Benjamin Verret, Heba Dawood, Laura Deiana, Marie‐Ange Mouret‐Reynier, Paule Augereau, Jean-Luc Canon, Noémie Huchet, C. Guyonneau, Jérôme Lemonnier, Gaëtan MacGrogan, Anthony Gonçalves, Élodie Darbo, Richard Iggo

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort

    Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort Autor Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, Florence Dalenc, Audrey Mailliez, Christelle Lévy, Véronique D’Hondt, Marc Debled, Thomas Vermeulin, Bruno Coudert, Christophe Perrin, Anthony Gonçalvès, Lionel Uwer, Jean-­Marc Ferrero, Jean‐Christophe Eymard, Thierry Petit, Marie‐Ange Mouret‐Reynier, Anne Patsouris, T. Guesmia, Thomas Bachelot, Mathieu Robain, Paul Cottu

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

    Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial Autor Philipp Harter, Marie Ange Mouret‐Reynier, Sandro Pignata, Claire Cropet, Antonio González‐Martín, Gerhard Bogner, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Trine Jakobi Nøttrup, Anne Floquet, Ahmed El‐Balat, Giovanni Scambia, Eva Maria Guerra Alía, Michel Fabbro, Barbara Schmalfeldt, Anne‐Claire Hardy‐Bessard, Ingo B. Runnebaum, Éric Pujade-Lauraine, Isabelle Ray‐Coquard

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

    Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study Autor Suzette Delaloge, David Pérol, Coralie Courtinard, Étienne Brain, Bernard Asselain, Thomas Bachelot, Marc Debled, Véronique Dièras, Mario Campone, Christelle Lévy, William Jacot, Véronique Lorgis, Corinne Veyret, Florence Dalenc, Jean‐Marc Ferrero, L. Uwer, Pierre Kerbrat, Anthony Gonçalvès, Marie‐Ange Mouret‐Reynier, Thierry Petit, Christelle Jouannaud, Laurence Vanlemmens, G. Chenuc, T. Guesmia, Mathieu Robain, C. Cailliot

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer

    Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer Autor Paul Cottu, Véronique D’Hondt, Sylvain Dureau, F. Lerebours, Isabelle Desmoulins, Pierre-Étienne Heudel, FP Duhoux, Christelle Lévy, Marie‐Ange Mouret‐Reynier, Florence Dalenc, Jean‐Sébastien Frenel, Christelle Jouannaud, Laurence Venat‐Bouvet, Suzanne Nguyen, J-M. Ferrero, Jean Luc Canon, John‐Paul Grenier, Céline Callens, David Gentien, Jérôme Lemonnier, Anne Vincent‐Salomon, Suzette Delaloge

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

    The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME) Autor David Pérol, Mathieu Robain, Patrick Arveux, Simone Mathoulin‐Pélissier, Emmanuel Chamorey, Bernard Asselain, Delphine Berchery, Sophie Gourgou, Mathias Breton, Stéphanie Delaine-Clisant, M. Mons, Véronique Dièras, Matthieu Carton, Anne‐Valérie Guizard, Lilian Laborde, Carine Laurent, Agnès Loeb, Marie‐Ange Mouret‐Reynier, D. Parent, G. Perrocheau, L. Campion, Michel Velten, Christian Cailliot, Monia Ezzalfani, G. Simon

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

    Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial Autor Isabelle Ray‐Coquard, Aude-Marie Savoye, Camille Schiffler, Marie‐Ange Mouret‐Reynier, Olfa Derbel, Elsa Kalbacher, Marianne Leheurteur, Alejandra Martínez, Corina Cornila, Mathilde Martinez, L. Bengrine Lefevre, Frank Priou, Nicolas Cloarec, Laurence Venat, Frédèric Selle, Dominique Berton-Rigaud, Olivier Collard, Elodie Coquan, Olivia Le Saux, Isabelle Treilleux, Sophie Gouérant, Antoine Angelergues, Florence Joly, Olivier Trédan

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

    Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort Autor Amélie Darlix, G. Louvel, Julien Fraisse, William Jacot, Étienne Brain, Marc Debled, Marie Ange Mouret‐Reynier, Anthony Gonçalvès, Florence Dalenc, Suzette Delaloge, Mario Campone, Paule Augereau, Jean Marc Ferrero, Christelle Lévy, Jean-David Fumet, I. Lecouillard, Paul Cottu, Thierry Petit, Lionel Uwer, Christelle Jouannaud, Marianne Leheurteur, Véronique Dièras, Mathieu Robain, Michaël Chevrot, Dominique Pasquier, Thomas Bachelot

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

    Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort Autor Thomas Grinda, Alison Antoine, William Jacot, Céline Blaye, Paul Cottu, Véronique Dièras, Florence Dalenc, A. Gonçalves, Marc Debled, Anne Patsouris, Marie‐Ange Mouret‐Reynier, Audrey Mailliez, Florian Clatot, Christelle Lévy, Jean-­Marc Ferrero, Isabelle Desmoulins, L. Uwer, Thierry Petit, Christelle Jouannaud, Magali Lacroix‐Triki, Élise Deluche, Mathieu Robain, Coralie Courtinard, Thomas Bachelot, Étienne Brain, David Pérol, Suzette Delaloge

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer

    Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer Autor Amanda Bortolini Silveira, François‐Clément Bidard, Marie‐Laure Tanguy, Elodie Girard, Olivier Trédan, Coraline Dubot, William Jacot, Anthony Gonçalvès, Marc Debled, Christelle Lévy, Jean-­Marc Ferrero, Christelle Jouannaud, María Rios, Marie‐Ange Mouret‐Reynier, Florence Dalenc, Caroline Hego, Aurore Rampanou, Benoît Albaud, Sylvain Baulande, Frédérique Berger, Jérôme Lemonnier, Shufang Renault, Isabelle Desmoulins, Charlotte Proudhon, Jean‐Yves Pierga

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: